These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2801095)

  • 1. Proliferation-associated monoclonal antibodies: a useful tool for prognosis in squamous cell carcinomas of head and neck?
    Lörz M; Meyer-Breiting E; Bettinger R; Desloovere C; Klima A
    Acta Otorhinolaryngol Belg; 1989; 43(1):41-6. PubMed ID: 2801095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transferrin receptors in squamous epithelial cancers of the head and neck].
    Lörz M; Meyer-Breiting E
    Laryngorhinootologie; 1991 Jan; 70(1):36-40. PubMed ID: 2025345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
    Fischer C; Zlobec I; Stöckli E; Probst S; Storck C; Tornillo L; Lugli A; Wolfensberger M; Terracciano L
    Hum Pathol; 2008 Oct; 39(10):1527-34. PubMed ID: 18620726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Low I; Ng D; Brasch H; Sullivan M; Davis P; Tan ST
    Hum Pathol; 2008 Mar; 39(3):344-9. PubMed ID: 18045646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are epidermal growth factor and transforming growth factor responsible for pseudoepitheliomatous hyperplasia associated with granular cell tumors?
    Barkan GA; Paulino AF
    Ann Diagn Pathol; 2003 Apr; 7(2):73-7. PubMed ID: 12715330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
    O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
    Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
    Homma A; Furuta Y; Oridate N; Nakano Y; Kohashi G; Yagi K; Nagahashi T; Yagi K; Nagahashi T; Fukuda S; Inoue K; Inuyama Y
    Clin Cancer Res; 1999 Apr; 5(4):801-6. PubMed ID: 10213215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monoclonal antibodies versus epithelial antigens and carcinomas of the head and neck: critical analysis of the possible clinical applications].
    Cavallo GP; Macario M; Regina S; Poggio E; Prat M; Morra B; Cortesina G
    Acta Otorhinolaryngol Ital; 1987; 7(1):77-85. PubMed ID: 3618206
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation of biomarkers in head and neck squamous cell carcinoma.
    Tse GM; King AD; Yu AM; Lam CC; Chan AW; Chen GG; Yeung DK; Yu KH; Bhatia KS; Chan AB
    Otolaryngol Head Neck Surg; 2010 Dec; 143(6):795-800. PubMed ID: 21109080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The EGF receptor system in head and neck carcinomas and normal tissues. Immunohistochemical and quantitative studies.
    Christensen ME
    Dan Med Bull; 1998 Apr; 45(2):121-34. PubMed ID: 9587699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor activity of monoclonal antibody CIBCNSH3 generated to the human EGF receptor.
    Udayachander M; Dean CJ; Meenakshi AN; Sivakumar N; Babu PB; Sivakumar J
    Hum Antibodies; 1997; 8(2):60-4. PubMed ID: 9289389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical determination of the appropriate anti-hTERT antibodies for in situ detection of telomerase activity in frozen sections of head and neck squamous cell carcinomas and tumor margin tissues.
    Fabricius EM; Kruse-Boitschenko U; Khoury R; Wildner GP; Raguse JD; Klein M
    Int J Oncol; 2009 May; 34(5):1257-79. PubMed ID: 19360339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy.
    Hitt R; Ciruelos E; Amador ML; Benito A; Sanchez JJ; Ballestin C; Cortes-Funes H
    Eur J Cancer; 2005 Feb; 41(3):453-60. PubMed ID: 15691646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer patients.
    Crombet T; Osorio M; Cruz T; Roca C; del Castillo R; Mon R; Iznaga-Escobar N; Figueredo R; Koropatnick J; Renginfo E; Fernández E; Alvárez D; Torres O; Ramos M; Leonard I; Pérez R; Lage A
    J Clin Oncol; 2004 May; 22(9):1646-54. PubMed ID: 15117987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoclonal antibody UW 21/123: clinical use and diagnostic specificity in head and neck cancers].
    Zenner HP; Herrmann IF; Moser L
    Laryngol Rhinol Otol (Stuttg); 1986 May; 65(5):287-91. PubMed ID: 3016433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of cell proliferation using monoclonal antibodies. Studies of 21 squamous cell carcinomas of the head and neck area].
    Lörz M; Meyer-Breiting E
    Laryngol Rhinol Otol (Stuttg); 1988 Oct; 67(10):539-42. PubMed ID: 3070247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of anti-epidermal growth factor receptor monoclonal antibodies and cisplatin in ten human head and neck squamous cell carcinoma lines.
    Hoffmann T; Hafner D; Ballo H; Haas I; Bier H
    Anticancer Res; 1997; 17(6D):4419-25. PubMed ID: 9494544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells.
    Rubin Grandis J; Chakraborty A; Melhem MF; Zeng Q; Tweardy DJ
    Oncogene; 1997 Jul; 15(4):409-16. PubMed ID: 9242377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of monoclonal antibody CIBCNSH3 generated to the human EGF receptor.
    Udayachander M; Meenakshi A; Sivakumar N; Kumar RR; Shankar SG; Dean CJ; Modjtahedi H
    Hum Antibodies; 1999; 9(3):149-54. PubMed ID: 10690627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.